Sirt1 improves healthy ageing and protects from metabolic syndrome-associated cancer

Daniel Herranz, Maribel Muñoz-Martin, Marta Cañamero, Francisca Mulero, Barbara Martinez-Pastor, Oscar Fernandez-Capetillo and Manuel Serrano ()
Additional contact information
Daniel Herranz: Tumor Suppression Group, Spanish National Cancer Research Center, 3 Melchor Fernandez Almagro Street, Madrid E-28029, Spain.
Maribel Muñoz-Martin: Tumor Suppression Group, Spanish National Cancer Research Center, 3 Melchor Fernandez Almagro Street, Madrid E-28029, Spain.
Marta Cañamero: Comparative Pathology Unit, SpanishNational Cancer Research Center, 3 Melchor Fernandez Almagro Street, Madrid E-28029, Spain.
Francisca Mulero: Molecular Imaging Unit, Spanish National Cancer Research Center, 3 Melchor Fernandez Almagro Street, Madrid E-28029, Spain.
Barbara Martinez-Pastor: Genomic Instability Group, Spanish National Cancer Research Center, 3 Melchor Fernandez Almagro Street, Madrid E-28029, Spain.
Oscar Fernandez-Capetillo: Genomic Instability Group, Spanish National Cancer Research Center, 3 Melchor Fernandez Almagro Street, Madrid E-28029, Spain.
Manuel Serrano: Tumor Suppression Group, Spanish National Cancer Research Center, 3 Melchor Fernandez Almagro Street, Madrid E-28029, Spain.

Nature Communications, 2010, vol. 1, issue 1, 1-8

Abstract: Abstract Genetic overexpression of protein deacetylase Sir2 increases longevity in a variety of lower organisms, and this has prompted interest in the effects of its closest mammalian homologue, Sirt1, on ageing and cancer. We have generated transgenic mice moderately overexpressing Sirt1 under its own regulatory elements (Sirt1-tg). Old Sirt1-tg mice present lower levels of DNA damage, decreased expression of the ageing-associated gene p16Ink4a, a better general health and fewer spontaneous carcinomas and sarcomas. These effects, however, were not sufficiently potent to affect longevity. To further extend these observations, we developed a metabolic syndrome-associated liver cancer model in which wild-type mice develop multiple carcinomas. Sirt1-tg mice show a reduced susceptibility to liver cancer and exhibit improved hepatic protection from both DNA damage and metabolic damage. Together, these results provide direct proof of the anti-ageing activity of Sirt1 in mammals and of its tumour suppression activity in ageing- and metabolic syndrome-associated cancer.

Date: 2010
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.nature.com/articles/ncomms1001 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:1:y:2010:i:1:d:10.1038_ncomms1001

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/ncomms1001

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().